| Name | Title | Contact Details |
|---|---|---|
Emily Wilkins |
Vice President of Compliance & Quality | Profile |
Jonathan Rider |
Chief Information Officer | Profile |
Laboratory Specialists is a Toledo, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Founded in 1985, Clinical Research Dental is the proud Canadian distributor for a number of internationally renowned dental manufacturers, including Clinician`s Choice, Ultradent, Bioclear, 3M, Cosmedent, Triodent, Komet and Ribbond. The company is also a leading provider of continuing education programs for dentists, and hosts 40 to 50 seminars and hands-on courses across Canada each year.
At ReSound, people with hearing loss are at the heart of everything we do. We think big and challenge the norm, because we believe Smart Hearing has the power to transform lives. Our award-winning Smart Hearing aids help people feel more involved, connected and in control. They deliver the best sound quality and optimal design. Smart Hearing aids also work like wireless stereo headphones, streaming sound directly to the hearing aids from devices like an iPhone® or a TV. An accompanying app gives full control and the ability to personalize each hearing experience. ReSound hearing aids are exclusively available through hearing care professionals, who adjust them to each individual`s specific hearing loss. With research teams in USA and Holland, we are headquartered in Denmark. ReSound is part of the GN Group, pioneering great sound from world leading ReSound hearing aids to Jabra office headsets and sports headphones. Founded in 1869, building on a strong legacy of innovative audio and communications solutuions, and listed on NSDAQ OMX Copenhagen, GN makes life sound better.
Microbot Medical was founded with the vision of pioneering Micro Invasive Surgery, transforming one of the biggest trends in healthcare - Minimally Invasive Surgery (estimated to be close to $20B by 2015); the company will provide transformational micro invasive technologies with the accuracy of robots and automated instruments to assist physicians in targeting the disease site with exquisite precision. Microbot will solve one of the largest unmet needs in the medical field, where morbidity as a result of surgery is more frequently due to trauma involved in gaining access to the area to perform the intended procedure rather than from the procedure itself. Through its unique platforms, Microbot will reach multiple surgical spaces, capitalizing on the fact that minimally invasive techniques have been applied to most of the surgical specialties. Microbot`s ViRob platform is an Autonomous Advancing Micro Robot (AAMR), less then 1mm in diameter, which has the ability to advance (forward/backward) within cavities/lumens (such as the typical human body`s veins and arteries). The TipCat platform is a self-propelled, flexible, see & treats endoscope/catheter. It is comprised of a series of interconnected balloons that provide forward and backward motion while allowing for a working channel to be available during the procedure. In developing its platforms, the company is focusing on multi-disciplinary platform of products.
Modern lifestyles and persistent near vision utilization cause a majority of patients to experience the reduced visual acuity and painful symptoms of eye misalignment – headaches, eye strain, neck and shoulder pain, motion sickness and dry eye sensation. Neurolens addresses common binocular vision issues using a three-step process. Step one is efficiently identifying patient symptomology using a basic online symptom screener that every patient can complete in minutes. This information goes directly to the Neurolens Measurement Device, Gen 2—or NMD2—ready for step two, which is accurately and objectively measuring the patient`s level of misalignment. The NMD2 is an objective, accurate and repeatable way to measure eye misalignment as small as 0.01 Prism Diopters. Most importantly, step three is correcting eye misalignment with a proven lens solution. Neurolenses address binocular vision issues by providing a contoured prism lens design that gradually delivers more prism in the lens corridor from distance to near. Neurolenses are proven to have a profound impact on a patient`s visual clarity and comfort. In fact, 93% of patients responded positively to wearing Neurolenses. Over 81% of patients suffering from chronic daily headaches reported their symptoms were substantially reduced or basically gone after wearing Neurolenses for 90 days. Neurolens—recognized in 2022 as one of the 30 fastest growing private companies in the healthcare industry by Inc. Magazine—is confident that appropriately addressing growing binocular vision issues will become a standard of care in this industry, unlocking dramatic patient outcomes and practice growth.